ADVERTISEMENT
ADVERTISEMENT
Rare, neuro drugs near a breakthrough moment
New tools and diagnostic capabilities were discussed at the USA–India Chamber of Commerce’s BioPharma & Healthcare Summit in Boston
-
1759953093.png)
Staff Reporter - Thu, 30, Apr 2026
- 16:23 EDT
- 17
Panel discussion at USA–India Chamber of Commerce’s BioPharma & Healthcare Summit in Boston / New India Abroad
Breakthroughs in neuroscience, rare diseases and precision medicine are bringing the biopharma industry closer to long-awaited advances, but challenges in regulation, patient selection and clinical trials continue to slow progress, industry leaders said at a high-level panel.
At the USA–India Chamber of Commerce’s BioPharma & Healthcare Summit in Boston, executives said new tools, better targets and emerging modalities are reshaping how companies approach complex neurological and rare diseases.
This post is for paying subscribers only
SUBSCRIBE NOWADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login